Healthcare - Biotechnology - NASDAQ - US
$ 4.12
-8.24 %
$ 134 M
Market Cap
-1.38
P/E
BALANCE SHEET
143 M
ASSETS
34.6 M
LIABILITIES
108 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
PepGen Inc.
| Current Assets | 113 M |
| Cash & Short-Term Investments | 110 M |
| Receivables | 0 |
| Other Current Assets | 2.27 M |
| Non-Current Assets | 30.4 M |
| Long-Term Investments | 0 |
| PP&E | 28.4 M |
| Other Non-Current Assets | 1.99 M |
| Current Liabilities | 17.5 M |
| Accounts Payable | 1 M |
| Short-Term Debt | 6.01 M |
| Other Current Liabilities | 10.5 M |
| Non-Current Liabilities | 17.1 M |
| Long-Term Debt | 17.1 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 80.8 | 181.8 | 132.9 | 9.8 | 3.5 |
| Short Term Investments | 29.6 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 58 K | 4.7 | 0.4 | 0.2 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.3 | 4.3 | 2.3 | 0.1 | 0.3 |
| Total Current Assets | 112.7 | 186.1 | 140.0 | 10.3 | 3.8 |
| PP&E | 28.4 | 29.9 | 0.6 | 0.3 | 0.4 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 1.5 | 1.5 | 0 | 0 |
| Other Long Term Assets | 2.0 | 0 | 1.5 | 0 | 1 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 143.1 | 217.4 | 143.6 | 10.6 | 4.2 |
| LIABILITIES | |||||
| Accounts Payable | 1.0 | 1.4 | 3.2 | 0.7 | 0.1 |
| Short Term Debt | 6.0 | 11.1 | 0 | 0 | 0 |
| Other Current Liabilities | 10.5 | 3.1 | 7.1 | 0.1 | 0.2 |
| Total Current Liabilities | 17.5 | 18.8 | 10.3 | 0.8 | 0.3 |
| Long Term Debt | 17.1 | 19.0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0.2 | 30 K | 0 |
| Total Liabilities | 34.6 | 37.8 | 10.5 | 0.9 | 0.3 |
| EQUITY | |||||
| Common Stock | 2 K | 2 K | 0 | 0 | 0 |
| Retained Earnings | (181.5) | (102.9) | (33.8) | (6.5) | (2.4) |
| Other Accumulative Comprehensive Income/Loss | 34 K | 81 K | 17 K | 8 K | 8 K |
| Total Equity | 108.4 | 179.6 | 133.1 | 9.8 | 3.9 |
| Total Liabilities and Equity | 143.1 | 217.4 | 143.6 | 10.6 | 4.2 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 23.8 | 23.7 | 22.4 | 22.4 | 22.4 |